Skip to content
BidBenchmark
Special NoticeAmendment 2

6505--Lab Supplies | Radiopharm | New 5 year consolidation Lebanon & Pittsburgh - Illuccix | 595 and 646 | EDA: 10/01/2026 VLD | Status: moved to collaboration, once actionable will be assigned to Christa S, CO Cindy L (7/16/2 (VA-27-00002334)

244-NETWORK CONTRACT OFFICE 4 (36C244)

Response status

Historical record

Aug 14, 2026, 2:00 PM UTC

This notice is no longer open.

Posted
Aug 11, 2026
Archive date
Sep 13, 2026
SAM status
Active
This is a preserved solicitation record. The response window is closed because the published deadline passed.

Answer-first brief

What the source record says

  • 244-NETWORK CONTRACT OFFICE 4 (36C244) published this special notice.
  • The notice uses NAICS 325412 (Pharmaceutical Preparation Manufacturing).

Procurement identity

Notice ID
433ff3c13f1a4c2182dc439f6c397d36
Solicitation
36C24426Q0883
Base type
Special Notice
Version
2 of 2

Solicitation facts

Structured fields from the current SAM notice version. A dash means the source did not publish a value.

Notice type
Special Notice
Solicitation number
36C24426Q0883
Set-aside
Set-aside code
Posted
Aug 11, 2026
Responses due
Aug 14, 2026, 2:00 PM UTC
Archive date
Sep 13, 2026
Archive type
autocustom
Base type
Special Notice
Organization type
OFFICE
Benchmark category
Category confidence
Category source
Last seen
Sep 5, 2026

Buyer and place

Office hierarchy and place of performance as published.

Department
VETERANS AFFAIRS, DEPARTMENT OF
Department code
Subagency
VETERANS AFFAIRS, DEPARTMENT OF
Subagency code
Office
244-NETWORK CONTRACT OFFICE 4 (36C244)
Organization path
Organization path codes
Office address
PITTSBURGH, PA, 15215, USA
Place of performance
City code
State
State code
Postal code
Country

Points of contact

Contact details from the current notice version.

Notice description

Source text reproduced without an AI summary.

INTENT TO SOLE SOURCE The Department of Veterans Affairs, Network Contracting Office 4 (NCO4) intends to sole source a consolidated contract for Ga-68 Illucix and Ga-68 Netspot Radiopharmaceuticals for the VA Pittsburgh Healthcare System and Lebanon VA Medical Center. All work is to be completed in accordance with statement of work. This sole source contract will be solicited and negotiated with Cardinal Health,414, LLC 7000 Cardinal Place, Dublin, Ohio 43017, under the authority of RFO 6.104-1 F&R Determination. See attached Draft Statement of Work (SOW). The North American Industry Classification System (NAICS) code for this procurement is 325412. The Small Business Administration (SBA) standard is 1300. Interested vendors that can meet this requirement shall identify their interest and capability, and respond to this notice by 08/14/2026 by 10:00 AM EST. Interested vendors must send a capability statement, no more than one page in length; to include Company Name, ueiSAM Number, Socioeconomic Category, brief description of your business entities capability to handle this project at Lebanon and Pittsburgh VA Medical Centers. This Special Notice of Intent to Sole Source is for planning purposes only. No solicitation will be made available. This is NOT a request for quotations. All information shall be provided at no cost or obligation to the Government. Responses must be sent via email to the Contracting Specialist at christa.stine@va.gov. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon the responses to this notice is solely at the discretion of the Government. If no responses are received, Contracting will proceed with the sole source negotiation with Cardinal Health, 414, LLC. STATEMENT OF WORK (SOW) Title of Project: Illucix (Gallium 68 PSMA-11) and NETSPOT (Ga-68 Dotatate) for Lebanon and Pittsburgh VA Medical Centers Nuclear Medicine Program. Scope of Work: The contractor shall provide timely delivery of name brand only radiopharmaceuticals in the form of Illucix (Gallium 68 PSMA-11) and NETSPOT (Ga-68 Dotatate) to Lebanon and Pittsburgh VA Medical Centers as defined in this statement of need. The distributor must be located within the 68 minute half-life of the Radiopharmaceutical to each facility. Background: Lebanon and Pittsburgh VA Medical Centers have a need to establish a contract for delivery and inventory management of name brand only radiopharmaceutical, Illucix (Gallium 68 PSMA-11) and NETSPOT (Ga-68 Dotatate) for their Nuclear Medicine program. Contractors who supply products from non-High Enriched Uranium sources (non-HEU) are preferred. Illucix is an advanced radioactive PET imaging tracer that is designed to help detect the presence of prostate-specific membrane antigen (PSMA) cancer cells in the body. Type of Contract: Firm-fixed priced, Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Sole Source: Cardinal Health is the only distributor within the 68 minute half-life of the Radiopharmaceutical to each Lebanon and Pittsburgh VA Medical Centers. Period of performance: The government is requesting a period of performance beginning October 1, 2026, through September 30, 2031. General Requirements: 1. Contractor shall be able to provide an adequate supply of product to meet the requirements of the Lebanon and Pittsburgh VA Medical Centers. 2. Contractor shall provide a barcode labeled insert to allow scanning data into existing nuclear medicine information management system (NMIS) or other dose tracking system. Contractor product barcode system shall be compatible with Nuclear Medicine Information Systems (NMIS) in general. 3. Contractor shall hold a current unrevoked NRC and/or agreement state radioactive materials license, which in addition to other license conditions, would allow for the receipt and disposal of radioactive material, and FDA license to produce and distribute radiopharmaceuticals for human administration, and be able to provide a copy of their radioactive material license with their proposal. 4. Contractor shall immediately notify the Contracting Officer and Contracting Officer Representative, upon any action by the NRC or an agreement state and/or FDA to suspend or modify the radioactive materials license. 5. Contractor shall meet all Nuclear Regulatory Commission (NRC), Department of Transportation, FDA, OSHA and all other agency rules and regulations (Federal and State), and must maintain all applicable certifications throughout the performance of contract. 6. Contractor shall provide evidence of special driver s licenses (competency) due to transporting hazardous materials. Contractor shall meet all Nuclear Regulatory Commission, Department of Transportation, F.D.A., OSHA and all other agency rules and regulations (Federal and State). 7. Contractor shall perform all quality control procedures as required by Federal and State regulatory agencies prior to shipment. Contractor shall test all products for Quality Control at an agreed upon frequency and only those products that pass QC measurements may be sent to the VA. This testing shall be performed at no cost to the VA. The contractor will provide a detailed description of the test upon request. 8. Contractor shall pick up scheduled items, used and unused, for proper disposal at no cost to the Government. 9.Contractor shall accept returns for credit under the following conditions: Product(s) shipped in error. Product(s) damaged in shipment Concealed shipping damages Recalled product(s) Outdated products in unopened, original container (specifically authorized for return by manufacturer). 10. Contractor/supplier shall abide by (CFR 10) Title Code of Federal Regulations, which states: A Licensee may use for medical use only: a. By-product material manufactured, labeled, packaged, and distributed in accordance with a license issued pursuant to the regulations in Title 10, Code of Federal Regulations, Part 35 and the equivalent regulations of an Agreement State. b. Reagent kits that have been manufactured, labeled, packed and distributed in accordance with the approval by the Commission pursuant to S32.73 or an Agreement State under equivalent regulations for the preparation of radiopharmaceuticals for medical use. 11. Contractor must adhere to the provisions of Health Insurance Portability and Accountability Act (HIPAA) of 1996 and the National Standards to Protect the Privacy and Security of Protected Health Information (PHI) as required by complying with rules governing the security, use and disclosure of protected health information by covered entities, including the Department of Veteran Affairs. 12. Any proposed substitution of product shall have the written approval of the VA Nuclear Medicine Service and the Contracting Officer or his/her designee. 13. Any defective or inferior products shall be replaced within the timeline specified at no cost to the VA. This includes damage during transit and will be the responsibility of the contractor to contact the POC and contracting officer within 24 hours after loss or damage of materials known by the contractor. The contractor shall be responsible for initiating action to replace all damaged or missing material at no additional cost to the government. 14. All radiopharmaceuticals shall be delivered in ready-to-use unit dose form in lead shield containers and plastic shrink wrap fitted at union of the container cap and base to ensure untampered seal. Product information must include supplier s source of radiopharmaceuticals, package inserts, results of quality control testing performed by supplier and copies of supplier s license at no additional cost. 15. All radiopharmaceuticals shall be calibrated and labeled with the patients name, concentration, calibration, time, total volume, total activity, lot number and prescription number. 16. No overage charges will be accepted. Any cost to replace damaged or incorrect products will be the responsibility of the contractor. Replacements shall be received within three (3) hours of notification by the VA. Ordering: Orders for Illucix (Gallium 68 PSMA-11) and/or NETSPOT (Ga-68 Dotatate) will be placed on an as needed basis. On-line orders can also be placed when permissible. The Nuclear Pharmacy will package and deliver individual unit dose for each patient on the date and calibration time specified when order was placed. Only Nuclear Medicine Technologists are authorized to place radiopharmaceutical orders. Normal orders shall be placed during the workday, and delivery shall be made to the Lebanon and Pittsburgh VA Medical Centers, Nuclear Medicine Department on the date and calibrated time specified at the time of order placement. Due to the demands of the Medical Center patient care requirements, contractor shall provide routine delivery and pick-up as many times as required by the Lebanon and Pittsburgh VA Medical Centers. In the event that the requirements may be determined in advance, a longer delivery time may be scheduled accordingly. In accordance with the following: The delivery order shall include the following information: contract item(s) and quantity, time(s) of delivery, and applicable VA order number. Orders can be placed by the Lebanon and Pittsburgh VA Medical Centers via telephone, fax, or e-mail. Ordering Contact Information: Contractor shall provide contact information for the placement of orders for items listed in the Schedule of Supplies and Services The Lebanon VA Medical Center CORs assigned to this contract will be the only individuals authorized to place orders under this contract: POC: Jasir Nayati, Jasir.Nayati@va.gov POC: Amy Landis, Amy.Landis@va.gov POC: Imani Crumlin, Imani.Crumlin@va.gov The Pittsburg VA Medical Center POCs assigned to this contract will be the only individuals authorized to place orders under this contract: POC: Kenneth Disbio, Kenneth.Disibio@va.gov POC: Tika Dahal, Tika.Dahal@va.gov POC: Jared McKee, Jared.McKee@va.gov Emergency Ordering Procedures: An added cost is provided IAW with line items 1 & 2 of the schedule of items for the base for emergency preparation and delivery service of radiopharmaceuticals at other than normal working hours. Normal business hours are considered Monday through Friday: 7:00 am 4:30 pm. Federal Holidays: New Year s Day; Martin Luther King, Jr Day; President s Day; Memorial Day; Juneteenth; Independence Day; Labor Day; Columbus Day; Veterans Day; Thanksgiving Day; Christmas Day and any other day specifically declared by the President of the United States as a National holiday. Deliveries: All orders will be delivered on an agreed upon schedule between the contractor and the Department of Veteran Affairs prior to shipment. No delivery charge shall be made for additional deliveries during normal working hours, Lebanon: 7:00 a.m. 4:00 p.m., Pittsburgh: 6:30 a.m. 4:30 p.m. Delivery will be coordinated between the designated POC and the contractor. In the event that an after-hours must occur, those deliveries shall be made by contacting the medical center police to unlock the designated room at each facility for safe package delivery and storage. Delivery Locations: Lebanon VA Medical Center, 1700 S. Lincoln Ave. Lebanon, PA 17042. Building 1, room G025, Nuclear Medicine department. VA Pittsburgh Health System, University Drive, Pittsburgh PA 15215. Room BW-222, Nuclear Medicine department. All annual quantities are estimates. The contractor will only be paid for items and quantities ordered and delivered. Schedule of Supplies CLIN Product description Estimated Quantities/yr. 0001 Illucix (Gallium GA 68 PSMA-11)-LEB 108 unit doses 0002 Illucix (Gallium GA 68 PSMA-11)-PIT 150 unit doses 0003 NETSPOT (Ga 68 Dotatate) -PIT 60 unit doses

Comparable award range

Historical award values for work matched by the fixed rubric—not an estimate of this opportunity.

Low end (p25)$7,080
Median$22,639
High end (p75)$74,017
Comparable awards
50
Median
$22,639
Computed
Aug 14, 2026
Rubric
comparables@2026.08.1
Comparable award values describe completed contracts. They do not state the government's budget and are not a bid recommendation.

Comparable awards

The match score is decomposed so each comparison can be challenged.

AwardContractorValueAwardedScoreWhy it matched
PURCHASE OF BOOSTRIX PFS 0.5ML, TYPHIM VI, RABAVERT 1ML, HAVRIX TPL, HEPLISAV-B 20MCG 0.5MMCKESSON CORPORATION$25,863.68May 11, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
INV 7633644043 PR-504-000820 GUYANA CANCELLED FOR MCKESSONMCKESSON CORPORATION$19,605.60May 11, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
INV 7637193599 PR-515-000536 COSTA RICA CANCELLED FOR MCKESSONMCKESSON CORPORATION$20,501.16May 27, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
VOLUNTEER MEDICAL SUPPLIESMCKESSON CORPORATION$26,485.05Jul 14, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MEDICAL ORDER 517-26-008MCKESSON CORPORATION$34,583.11Jul 15, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MCKESSON REGULAR AND CONTROL MEDICATIONS FOR FCI DANBURY JUNE-SEPTEMBERMCKESSON CORPORATION$393,480.34Jul 14, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MCKESSON MAT MEDICATIONS FOR FCI DANBURY JUNE-SEPTEMBER EO 14398MCKESSON CORPORATION$52,719.00Jul 29, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
CONTRACT MEDICATIONS FOR JULY FY26- FCI LORETTOMCKESSON CORPORATION$90,000.00Jun 12, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
Q4 FY26 MCKESSON NARCOTIC CONTRACT MEDICATIONS FOR FCI LORETTOMCKESSON CORPORATION$300.00Jun 12, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
CONTRACT MEDICATIONS FCI LORETTOMCKESSON CORPORATION$202,293.29Jul 28, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FPC DULUTH FY26 MCKESSON CONTROLLED MEDICATION ORDER FOR Q3 FY26. ORDER ISSUED IN ACCORDMCKESSON CORPORATION$400.00Jul 8, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MEDICATIONSMCKESSON CORPORATION$9,781.02Jun 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MCKESSON MAT MEDICATION JUN 26MCKESSON CORPORATION$9,876.72Jun 10, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON MEDICATION JUN 26MCKESSON CORPORATION$3,334.35Jun 10, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON MEDICATION JUL 26MCKESSON CORPORATION$745.43Jul 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 FSA MCKESSON MAT MEDICATION JUL 26MCKESSON CORPORATION$9,310.25Jul 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON CONTROLLED MEDICATIONS JUL 26MCKESSON CORPORATION$29.70Jul 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MEDICATIONSMCKESSON CORPORATION$93,443.16Jun 10, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON OPEN MARKET MEDS QTR4MCKESSON CORPORATION$10,000.00Jun 16, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON NON-CONT/CONT. JULY 2026MCKESSON CORPORATION$65,000.00Jul 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)

Amendment history

A version is preserved whenever the normalized notice contents change.

VersionNotice typeObservedResponses dueContent hash
1Special NoticeAug 13, 2026Aug 14, 2026, 2:00 PM UTCe2b1d111fe433668
2Special NoticeAug 28, 2026Aug 14, 2026, 2:00 PM UTC949243f289b5636f

Record provenance

Field-level lineage for the current opportunity version.

FieldSourceSource as ofParserTransform
agency_nameSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_dateSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_typeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
base_typeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
contactsSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
descriptionSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
naics_codeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_idSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_typeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_citySAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_country_codeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_nameSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_postal_codeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_state_codeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
organization_typeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
posted_dateSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
psc_codeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
response_deadlineSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
sam_urlSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
solicitation_numberSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
subagency_nameSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
titleSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3
upstream_activeSAM.gov Contract OpportunitiesAug 13, 2026sam_opportunity_snapshot@2026.08.22026.08.3

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

Comparable awards are scored on benchmark category, product and service code, industry code, buyer, place, recency, and contract type. Rubric version comparables@2026.08.1.

  1. 1Notice fields come from the SAM.gov contract opportunities record last seen Sep 5, 2026. SAM.gov remains authoritative.
  2. 2Computed from 50 completed federal awards using comparables@2026.08.1, as of Aug 14, 2026. Award values are neither unit prices nor a forecast.

Note 1 covers the solicitation record; note 2 covers the comparable range. No synthetic FAQ or inferred solicitation value is published.